Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

449.35 -4.39 (-0.97%)

Streaming Delayed Price Updated: 9:51 AM EDT, Mar 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9

...

72 73 Next >

Vertex Pharmaceuticals Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

November 03, 2025

Via Benzinga

Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday? ↗

November 03, 2025

Wall Street opened the week on a mixed note on Monday.

Via Benzinga

2 Healthcare Stocks for Individual Investors With a 20-Year Time Horizon ↗

November 03, 2025

These healthcare stocks are making strides in very important ways.

Via The Motley Fool

Topics Intellectual Property

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

Inflation-Proof Investing: Which Growth Stock Will Double Your Money in 6 Years? ↗

November 03, 2025

These are great picks with or without soaring inflation.

Via The Motley Fool

Topics Economy Government World Trade

My Top Growth Stock to Buy in November ↗

November 02, 2025

This stock isn't bulletproof. But it should be a big winner over the coming years.

Via The Motley Fool

Vertex Pharmaceuticals (VRTX) Q3 Earnings: What To Expect

November 01, 2025

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be announcing earnings results this Monday after market hours. Here’s what you need to know.

Via StockStory

How Royalty Pharma Prints Cash Without Biotech's Biggest Risks ↗

October 31, 2025

Via MarketBeat

Here's How Much $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today ↗

October 30, 2025

Via Benzinga

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Fundamentals and Bullish Technical Setup ↗

October 29, 2025

Discover how Vertex Pharmaceuticals (VRTX) combines strong fundamentals, like high profitability and no debt, with a bullish technical breakout pattern for potential growth.

Via Chartmill

If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These ↗

October 28, 2025

These two have been neglected by Wall Street too much.

Via The Motley Fool

Vertex to Participate in the UBS Global Healthcare Conference on November 11

October 27, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030 ↗

October 27, 2025

Vertex appears to be by far the better buy right now.

Via The Motley Fool

Topics Intellectual Property

The Best Stocks to Invest $50,000 In Right Now ↗

October 24, 2025

There's no guarantee that any stock will deliver positive returns. But the odds look good for these three.

Via The Motley Fool

Topics Artificial Intelligence Energy

Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference

October 23, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A Value Investment Case Study ↗

October 20, 2025

Vertex Pharmaceuticals (VRTX) presents a value investing case with strong profitability, a debt-free balance sheet, and a valuation that appears attractive relative to its industry peers.

Via Chartmill

2 Growth Stocks to Invest $1,000 in Right Now ↗

October 19, 2025

These companies have a habit of beating the market, and they are far from having peaked.

Via The Motley Fool

Topics Artificial Intelligence World Trade

Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week

October 17, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

2 Soaring Cathie Wood Stocks to Buy and Hold ↗

October 17, 2025

These companies' market-beating fuel hasn't run out yet.

Via The Motley Fool

Vera Therapeutics' Lead Kidney Drug Poised For 2026 Launch In Multi-Billion-Dollar Market ↗

October 16, 2025

Bank of America initiates coverage on Vera Therapeutics, citing strong potential for atacicept, its kidney treatment.

Via Benzinga

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Offers Affordable Growth in Biotech ↗

October 15, 2025

Vertex Pharmaceuticals (VRTX) offers strong growth, solid earnings, and a robust financial position, all at a reasonable price compared to biotech peers.

Via Chartmill

2 Unstoppable Growth Stocks to Buy During a Market Crash ↗

October 15, 2025

Here are two smart ways to prepare for the next market downturn.

Via The Motley Fool

Topics Government Stocks World Trade

Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today ↗

October 14, 2025

Via Benzinga

4 Healthcare Stocks to Buy Now ↗

October 12, 2025

As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.

Via The Motley Fool

Topics Artificial Intelligence

Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity ↗

October 08, 2025

Via Benzinga

The Smartest Growth Stock to Buy With $500 Right Now ↗

October 08, 2025

Vertex isn't your run-of-the-mill biotech stock.

Via The Motley Fool

Topics Economy

Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q2 Earnings?

October 08, 2025

Over the past six months, Vertex Pharmaceuticals’s stock price fell to $413.23. Shareholders have lost 12.5% of their capital, which is disappointing considering the S&P 500 has climbed by 34.7%. This...

Via StockStory

Topics Stocks

Worried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500 ↗

October 07, 2025

Tariffs aren't likely to weigh on growth at these companies.

Via The Motley Fool

Topics Government Stocks World Trade

Vertex to Announce Third Quarter 2025 Financial Results on November 3rd

October 06, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years ↗

October 06, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.